Skip to main content
CSBR $4.92 +1.86%
CSBR logo
CSBR · Champions Oncology, Inc.
Track CSBR — free
$4.92 +0.09 (+1.86%) Q3 2026 earnings call transcript
Market Cap
$67.23M
Shares
13.92M
Volume · Oct 28 3145 Avg daily vol (3M) 11.13K
All webcasts

Earnings call · FY2027 Q1

Champions Oncology, Inc. (CSBR) Q1 2027 Earnings Call

Concluded Sep 10, 2026
Sep 10, 2026 0 turns
Period
FY2027 Q1
Runtime
—
Sources
2 artifacts
Revenue $15.23M +8.8% YoY
Gross margin · derived Q4 50.5% +7.6 pp YoY
Net income -$426,000
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Pharmacology Services$14.16M +7% YoY
Translational Oncology Solutions TOS License Revenue$893,000 +187.1% YoY
Product And Service Other$183,000 -59.7% YoY
Full-screen source Call document